These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15566504)

  • 1. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt.
    Hussein MR
    Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.
    Seki S; Sakaguchi H; Kitada T; Tamori A; Takeda T; Kawada N; Habu D; Nakatani K; Nishiguchi S; Shiomi S
    Clin Cancer Res; 2000 Sep; 6(9):3469-73. PubMed ID: 10999730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic alterations in liver cell tumors as detected by comparative genomic hybridization.
    Terracciano L; Tornillo L
    Pathologica; 2003 Apr; 95(2):71-82. PubMed ID: 12768875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
    Feng D; Zheng H; Shen M; Cheng R; Yan Y
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
    Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
    Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes.
    Gong L; Li YH; Su Q; Chu X; Zhang W
    Histopathology; 2010 Apr; 56(5):589-99. PubMed ID: 20459569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma.
    Lee TK; Man K; Poon RT; Lo CM; Ng IO; Fan ST
    Oncol Rep; 2004 Jul; 12(1):25-31. PubMed ID: 15201954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
    van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE
    Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis.
    Park YN; Chae KJ; Kwon KW; Oh BK; Lee KS; Lee WJ; Park C
    Hepatogastroenterology; 2003; 50(53):1292-6. PubMed ID: 14571721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver.
    Quaglia A; Jutand MA; Dhillon A; Godfrey A; Togni R; Bioulac-Sage P; Balabaud C; Winnock M; Dhillon AP
    World J Gastroenterol; 2005 Oct; 11(40):6262-8. PubMed ID: 16419153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
    Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
    Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
    Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY
    Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
    de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
    Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of hcv in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR.
    Rullier A; Trimoulet P; Urbaniak R; Winnock M; Zauli D; Ballardini G; Rosenbaum J; Balabaud C; Bioulac-Sage P; Le Bail B
    Mod Pathol; 2001 May; 14(5):496-505. PubMed ID: 11353061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.